Stock 4507 SHIONOGI & CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company Shionogi & Co., Ltd.

Equities

4507

JP3347200002

Pharmaceuticals

Market Closed - Japan Exchange
Other stock markets
 02:00:00 2024-05-17 am EDT 		5-day change 1st Jan Change
7,129 JPY -1.14% Intraday chart for Shionogi & Co., Ltd. -4.81% +4.87%
May. 14 Japan's Nikkei drifts sideways as more earnings, US CPI awaited RE
May. 13 Japan's Shionogi says COVID treatment did not meet endpoint in late-stage trial RE

Business Summary

Shionogi & Co., Ltd. specializes in development, manufacturing and marketing of pharmaceutical products. The group's activity is organized around 3 families of products:

- prescription products: drugs for the treatment of cardiovascular and infectious diseases, diabetes, allergic reactions, etc.;

- OTC products: analgesic products, vitamins and tonics, etc.;

- diagnosis products: primarily for detection and treatment of cardiovascular diseases and immune system.

Number of employees: 4,959

Sales per Business

JPY in Million2022Weight2023Weight Delta
Pharmaceutical
100.0 %
335,138 100.0 % 426,684 100.0 % +27.32%

Sales per region

JPY in Million2022Weight2023Weight Delta
Japan
48.7 %
113,589 33.9 % 207,777 48.7 % +82.92%
United Kingdom
40.9 %
184,202 55.0 % 174,706 40.9 % -5.16%
Other
4.1 %
15,587 4.7 % 17,670 4.1 % +13.36%
United States
3.8 %
14,322 4.3 % 16,247 3.8 % +13.44%
Europe
2.4 %
7,427 2.2 % 10,276 2.4 % +38.36%
North America
0.0 %
8 0.0 % 6 0.0 % -25.00%

Managers

Managers TitleAgeSince
Isao Teshirogi CEO
 Chief Executive Officer 64 82-03-31
Yuji Hosogai DFI
 Director of Finance/CFO - -
Yasuetsu Imune CTO
 Chief Tech/Sci/R&D Officer - -
John Keller CTO
 Chief Tech/Sci/R&D Officer - -
Takuko Sawada BRD
 Director/Board Member 69 77-03-31
Yoshinori Yurugi PRN
 Corporate Officer/Principal - -
Aki Ikehata LAW
 General Counsel - -
Hirofumi Nagadome HRO
 Human Resources Officer - -
Harumi Shimai SAM
 Sales & Marketing - -
Takeshi Shiota PRN
 Corporate Officer/Principal - 14-12-31

Members of the board

Members of the board TitleAgeSince
Hiroshi Ozaki BRD
 Director/Board Member 74 19-05-31
Isao Teshirogi CEO
 Chief Executive Officer 64 82-03-31
Takuko Sawada BRD
 Director/Board Member 69 77-03-31
Keiichi Ando BRD
 Director/Board Member 72 16-05-31
Fumi Takatsuki BRD
 Director/Board Member 48 20-05-31

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 0 300,385,201 262,150,439 ( 87.27 %) 23,894,588 ( 7.955 %) 87.27 %

Shareholders

NameEquities%Valuation
Sumitomo Life Insurance Co.
6.274 %
18,604,000 6.274 % 872 M ¥
Nomura Asset Management Co., Ltd.
6.206 %
18,403,900 6.206 % 862 M ¥
SHIONOGI & CO., LTD.
3.390 %
10,052,488 3.390 % 471 M ¥
Sumitomo Mitsui Banking Pension Fund
3.199 %
9,485,000 3.199 % 444 M ¥
Nikko Asset Management Co., Ltd.
3.014 %
8,938,400 3.014 % 419 M ¥
BlackRock Fund Advisors
3.012 %
8,931,960 3.012 % 419 M ¥
Nippon Life Insurance Co.
2.836 %
8,409,000 2.836 % 394 M ¥
PING AN INSURANCE (GROUP) COMPANY OF CHINA, LTD.
2.143 %
6,356,000 2.143 % 298 M ¥
BlackRock Japan Co. Ltd.
2.075 %
6,154,600 2.075 % 288 M ¥
SUMITOMO MITSUI FINANCIAL GROUP, INC.
1.550 %
4,595,000 1.550 % 215 M ¥
NameEquities%Valuation
Todd Asset Management LLC
0.1641 %
1,946,777 0.1641 % 22 M ¥
Ativo Capital Management LLC
0.008847 %
104,946 0.008847 % 1 M ¥
RhumbLine Advisers LP
0.003064 %
36,350 0.003064 % 417 552 ¥
PNC Investments LLC
0.000983 %
11,661 0.000983 % 133 950 ¥
GAMMA Investing LLC
0.000252 %
2,989 0.000252 % 34 335 ¥
Operose Advisors LLC
0.000044 %
518 0.000044 % 5 950 ¥

Holdings

NameEquities%Valuation
SHIONOGI & CO., LTD.
3.39%
 10,052,488 3.39% 471,051,646 $
SUMITOMO MITSUI FINANCIAL GROUP, INC.
0.12%
 1,643,810 0.12% 93,803,672 $
TOHO HOLDINGS CO., LTD.
4.58%
 3,500,000 4.58% 83,916,385 $
SUZUKEN CO., LTD.
2.13%
 1,656,696 2.13% 49,080,265 $
KISSEI PHARMACEUTICAL CO., LTD.
1.85%
 914,000 1.85% 21,054,557 $
MEDIPAL HOLDINGS CORPORATION
0.57%
 1,271,605 0.57% 19,959,099 $
KANEKA CORPORATION
0.40%
 266,600 0.40% 6,930,771 $
STEMRIM
2.93%
 1,800,000 2.93% 5,330,286 $
ONO PHARMACEUTICAL CO., LTD.
0.07%
 344,095 0.07% 4,976,711 $
SUMITOMO MITSUI TRUST HOLDINGS, INC.
0.03%
 210,420 0.03% 4,436,651 $

Company contact information

Shionogi & Co., Ltd.

3-1-8 Dosho-machi Chuo-Ku

541-0045, Osaka

+81 6 6202 2161

http://www.shionogi.co.jp
address Shionogi & Co., Ltd.(4507)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per region

Ratings for Shionogi & Co., Ltd.

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
13
Last Close Price
7,211 JPY
Average target price
7,805 JPY
Spread / Average Target
+8.24%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
SHIONOGI & CO., LTD. Stock Shionogi & Co., Ltd.
+4.87% 13.17B
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+32.09% 694B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+29.29% 593B
JOHNSON & JOHNSON Stock Johnson & Johnson
-1.68% 371B
MERCK & CO., INC. Stock Merck & Co., Inc.
+19.81% 331B
ABBVIE INC. Stock AbbVie Inc.
+6.45% 290B
ASTRAZENECA PLC Stock AstraZeneca PLC
+14.08% 239B
ROCHE HOLDING AG Stock Roche Holding AG
-3.15% 209B
NOVARTIS AG Stock Novartis AG
+9.97% 209B
AMGEN INC. Stock Amgen Inc.
+8.03% 169B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 4507 Stock
  4. Company Shionogi & Co., Ltd.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW